Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Health and Healthcare

Published: December 10, 2008 11:04 am

It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be one of no conviction either way. Here are the short seller reports in the short interest:

Stock (Ticker)                      NOV. 28    NOV. 14    CHANGE
Amgen Inc. (AMGN)             23,033,081 24,169,278 -4.70%
Celgene Corporation (CELG) 8,298,820 8,040,642    +3.21%
Biogen Idec Inc. (BIIB)          8,027,848 7,938,637    +1.12%
Genzyme Corporation (GENZ) 6,569,181 6,797,501    -3.36%
Gilead Sciences (GILD)          29,055,791 30,213,915 -3.83%

Jon C. Ogg
December 10, 2008

It’s Your Money, Your Future—Own It (sponsor)

Retirement can be daunting, but it doesn’t need to be.

Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.